Abstract
This paper looks at the challenges, opportunities and strategies involved in building a global biotechnology company. There is no single global strategy that will answer all companies' needs; instead strategies will be dictated by the individual business development plans of a company, its products and its values.
Article PDF
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Geraghty, J. Strategies for building a global healthcare biotechnology company. J Commer Biotechnol 9, 339–344 (2003). https://doi.org/10.1057/palgrave.jcb.3040043
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1057/palgrave.jcb.3040043